Literature DB >> 20421523

Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation.

Peter I Bonta1, Thijs W H Pols, Claudia M van Tiel, Mariska Vos, E Karin Arkenbout, Jakub Rohlena, Karel T Koch, Moniek P M de Maat, Michael W T Tanck, Robbert J de Winter, Hans Pannekoek, Erik A L Biessen, Ilze Bot, Carlie J M de Vries.   

Abstract

BACKGROUND: Restenosis is the major drawback of percutaneous coronary interventions involving excessive activation and proliferation of vascular smooth muscle cells (SMCs). The nuclear receptor Nurr1 is an early response gene known mainly for its critical role in the development of dopamine neurons. In the present study, we investigated Nurr1 in human and experimental vascular restenosis. METHODS AND
RESULTS: In a prospective cohort of 601 patients undergoing percutaneous coronary intervention, including stent placement, we found a strong association between Nurr1 haplotypes and in-stent restenosis risk. Furthermore, Nurr1 is specifically expressed in human in-stent restenosis and induced in cultured human SMCs in response to serum or tumor necrosis factor-alpha. Lentivirus-mediated gain- and loss-of-function experiments in SMCs demonstrated that overexpression of Nurr1 inhibited proliferation, consistent with increased expression of the key cell-cycle inhibitor p27(Kip1), whereas Nurr1 silencing enhanced SMC growth. The tumor necrosis factor-alpha-induced proinflammatory response of SMCs is inhibited by Nurr1, as reflected by reduced interleukin-1beta, tumor necrosis factor-alpha, and monocyte chemoattractant protein-1 expression. Consistent with our in vitro data, endogenous Nurr1 reduced wire injury-induced proliferation and vascular lesion formation in carotid arteries of ApoE(-/-) mice.
CONCLUSIONS: Nurr1 haplotypes are associated with human restenosis risk, and Nurr1 is expressed in human in-stent restenosis. In SMCs, Nurr1 inhibits proliferation and inflammatory responses, which explains the inhibition of SMC-rich lesion formation in mice. The recently identified small-molecule drugs that enhance the activity of Nurr1 reveal this nuclear receptor as an attractive novel target for (local) intervention in restenosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20421523     DOI: 10.1161/CIRCULATIONAHA.109.885673

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  15 in total

Review 1.  Restenosis after PCI. Part 2: prevention and therapy.

Authors:  J Wouter Jukema; Tarek A N Ahmed; Jeffrey J W Verschuren; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2011-10-11       Impact factor: 32.419

2.  CCN4 regulates vascular smooth muscle cell migration and proliferation.

Authors:  Hao Liu; Wenpeng Dong; Zhiqi Lin; Jingbo Lu; Heng Wan; Zhongxin Zhou; Zhengjun Liu
Journal:  Mol Cells       Date:  2013-06-25       Impact factor: 5.034

3.  NR4A nuclear receptors in immunity and atherosclerosis.

Authors:  Anouk A J Hamers; Richard N Hanna; Heba Nowyhed; Catherine C Hedrick; Carlie J M de Vries
Journal:  Curr Opin Lipidol       Date:  2013-10       Impact factor: 4.776

Review 4.  Translational research on novel drug-eluting stents in percutaneous coronary intervention.

Authors:  Yaling Han; Kai Xu; Chenghui Yan
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

5.  Nuclear receptor 4A (NR4A) family - orphans no more.

Authors:  Stephen Safe; Un-Ho Jin; Benjamin Morpurgo; Ala Abudayyeh; Mandip Singh; Ronald B Tjalkens
Journal:  J Steroid Biochem Mol Biol       Date:  2015-04-23       Impact factor: 4.292

6.  Higher plasma level of STIM1, OPG are correlated with stent restenosis after PCI.

Authors:  Haibin Li; Zhian Jiang; Xiangdong Liu; Zhihui Yang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

7.  Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β) protein attenuates vascular lesion formation by inhibition of chromatin loading of minichromosome maintenance complex in smooth muscle cells.

Authors:  Yanhong Guo; Yanbo Fan; Jifeng Zhang; Lin Chang; Jiandie D Lin; Y Eugene Chen
Journal:  J Biol Chem       Date:  2012-12-21       Impact factor: 5.157

8.  Genetic analysis of ligation-induced neointima formation in an F2 intercross of C57BL/6 and FVB/N inbred mouse strains.

Authors:  Caroline Östergren; Jeong Shim; Jens Vinther Larsen; Lars Bo Nielsen; Jacob F Bentzon
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

9.  Inhibition of Epac1 suppresses mitochondrial fission and reduces neointima formation induced by vascular injury.

Authors:  Hui Wang; William G Robichaux; Ziqing Wang; Fang C Mei; Ming Cai; Guangwei Du; Ju Chen; Xiaodong Cheng
Journal:  Sci Rep       Date:  2016-11-10       Impact factor: 4.379

10.  Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer.

Authors:  Jian Wang; Zhi-Hong Yang; Hua Chen; Hua-Hui Li; Li-Yong Chen; Zhu Zhu; Ying Zou; Cong-Cong Ding; Jing Yang; Zhi-Wei He
Journal:  BMC Cancer       Date:  2016-03-31       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.